XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Tables)
 9 Months Ended
Sep. 30, 2021
Revenue From Contract With Customer [Abstract]  
Schedule Of Collaboration Revenue Revenue was as follows for the three and nine months ended September 30, 2021 and 2020:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Neurocrine Biosciences:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Recognition of the transaction price

 

$

823

 

 

$

5,246

 

 

$

1,440

 

 

$

23,006

 

    Research and development services

 

 

2,031

 

 

 

1,308

 

 

 

4,990

 

 

 

4,010

 

    Milestone payments

 

 

5,270

 

 

 

—

 

 

 

5,270

 

 

 

—

 

Flexion:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   Milestone payments

 

 

—

 

 

 

—

 

 

 

3,000

 

 

 

—

 

Total collaboration revenue

 

$

8,124

 

 

$

6,554

 

 

$

14,700

 

 

$

27,016